Latest News and Press Releases
Want to stay updated on the latest news?
-
Copenhagen, 2017-11-10 07:30 CET (GLOBE NEWSWIRE) -- Performance for the period (unaudited) (Comparative figures for 2016 are shown in brackets. Revenue growth is measured in local...
-
København, 2017-11-10 07:30 CET (GLOBE NEWSWIRE) -- Bemærk venligst, at kvartalsrapporten kun foreligger på engelsk. Performance for the period (unaudited) (Comparative...
-
Copenhagen, 2017-11-03 09:26 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) today announced the appointment of Søren Jelert as its new Chief Financial Officer (CFO) and...
-
København, 2017-11-03 09:26 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) meddeler i dag, at Søren Jelert er udnævnt som ny Chief Financial Officer og Executive Vice...
-
Copenhagen, 2017-11-03 08:23 CET (GLOBE NEWSWIRE) -- On Friday, 10 November 2017, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) releases its interim report for the nine months ended 30...
-
København, 2017-11-03 08:23 CET (GLOBE NEWSWIRE) -- ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) offentliggør delårsrapport for første ni måneder (Q3) 2017 fredag den 10. november 2017. ALK...
-
Copenhagen, 2017-10-12 22:43 CEST (GLOBE NEWSWIRE) -- Pursuant to section 29 of the Danish Securities Trading Act, ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) has received notification from...
-
København, 2017-10-12 22:43 CEST (GLOBE NEWSWIRE) -- I henhold til § 29 i Lov om værdipapirhandel m.v. har ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF) modtaget meddelelse fra Jupiter Asset...
-
København, 2017-09-27 09:00 CEST (GLOBE NEWSWIRE) -- CEDARCURE™ er den første tabletvaccine, der er godkendt i Japan til behandling af både voksne og børn. CEDARCURE™ fuldender...
-
Copenhagen, 2017-09-27 09:00 CEST (GLOBE NEWSWIRE) -- CEDARCURE™ is the first SLIT-tablet to be approved for both adult and paediatric use in Japan Joins the already launched...